CARBAMAZEPINE ESSENTIAL PHARMA

国家: 爱尔兰

语言: 英文

来源: HPRA (Health Products Regulatory Authority)

现在购买

资料单张 资料单张 (PIL)
10-05-2018
产品特点 产品特点 (SPC)
10-05-2018

有效成分:

CARBAMAZEPINE

可用日期:

Essential Pharma Ltd

ATC代码:

N03AF01

INN(国际名称):

CARBAMAZEPINE

剂量:

125 Milligram

药物剂型:

Suppositories

处方类型:

Product subject to prescription which may be renewed (B)

治疗领域:

carbamazepine

授权状态:

Not Marketed

授权日期:

1994-04-19

资料单张

                                Car125-250mgSupp/PL/IE/4
1
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT
CARBAMAZEPINE ESSENTIAL PHARMA 125 AND 250 MG SUPPOSITORIES
Carbamazepine
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE – BECAUSE IT CONTAINS IMPORTANT
INFORMATION FOR YOU.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist.

This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them, even
if their signs of illness are the same as yours.

If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side effects
not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Carbamazepine Essential Pharma Suppositories are and what they
are used for
2.
What you need to know before you use Carbamazepine Essential Pharma
Suppositories
3.
How to use Carbamazepine Essential Pharma Suppositories
4.
Possible side effects
5.
How to store Carbamazepine Essential Pharma Suppositories
6.
Contents of the pack and other information
1.
WHAT CARBAMAZEPINE ESSENTIAL PHARMA SUPPOSITORIES ARE AND WHAT THEY
ARE USED
FOR
Carbamazepine Essential Pharma Suppositories contain a medicine called
carbamazepine.
Carbamazepine can affect the body in several different ways.
Carbamazepine Essential Pharma
Suppositories help to control messages passed from the brain to
muscles along the nerve pathways in
the body. It is an anti-epileptic medicine (prevents fits).
Carbamazepine Essential Pharma Suppositories are used to treat some
forms of epilepsy in adults and
children, for up to 7 days, when treatment by mouth is not possible.
This might be if you are having an
operation, for example.
2.
WHAT YOU NEED TO KNOW BEFORE YOU USE CARBAMAZEPINE ESSENTIAL PHARMA
SUPPOSITORIES
DO NOT USE CARBAMAZEPINE ESSENTIAL PHARMA SUPPOSITORIES IF:

you are allergic to carbamazepine or similar medicines such as
oxcarbazepine (Trileptal), or to any of
a related group of medicines called tricyclic antidepressants
                                
                                阅读完整的文件
                                
                            

产品特点

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Carbamazepine Essential Pharma 125 mg Suppositories
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each suppository contains 125 mg carbamazepine
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Suppository
White to off-white, torpedo shaped suppositories with a fatty odour.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
As an anticonvulsant in the management of epilepsy (generalised
tonic-clonic and partial seizures).
Carbamazepine Essential
Pharma suppositories are for short-term use as replacement
therapy in patients where oral
treatment is temporarily not possible.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Carbamazepine Essential
Pharma is available in suppositories,
for short
term use. They are intended as replacement
therapy (maximum period recommended: 7 days) in patients for whom oral
treatment is temporarily not possible,
for
example in post-operative patients.
When switching from oral
formulations
of
Carbamazepine to suppositories
the dosage should be increased by
approximately 25% (the 125 mg and 250 mg suppositories correspond to
the 100 and 200 mg tablets respectively).
The final
dose adjustment
should always depend on the clinical
response in the individual
patient. Carbamazepine
Essential Pharma suppositories, in appropriate doses, have been shown
to provide plasma levels which are well within
the therapeutic range.
The pharmacokinetic properties of the suppositories are such that the
maximum daily dose is limited to 1000 mg (250
mg four times daily at 6 hourly intervals).
_USE IN THE ELDERLY:_
Due to the potential for drug interactions, the dosage of
Carbamazepine Essential Pharma should be selected with
caution in elderly patients.
_USE IN PAEDIATRIC PATIENTS:_
Carbamazepine Essential Pharma suppositories are not recommended for
very young children.
SPECIAL POPULATIONS
RENAL IMPAIRMENT / HEPATIC IMPAIRMENT
No data are available on the pharmacokinetics of carbamazepine in
patients with impaired hepatic or renal
                                
                                阅读完整的文件
                                
                            

搜索与此产品相关的警报